RxDoctor Payments Data

Nicole Brouyette

Foot & Ankle Surgery · Dearborn, MINPI 1386907186

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $44,509 of the $71,288 with a category attached, or 62.4%. Paragon 28, Inc. accounts for 81.9% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $33,276 and has fallen 82.9% since, to $5,697 in 2025. Among foot & ankle surgery clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$71,288in general payments, 2019–2025

Across 146 payments — averaging $488.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$58K
  • Synthes GmbH$6K
  • Pinnacle, Inc$2K
  • Stryker$2K
  • Arthrex$468
  • Nevro Corp.$314
  • plus $1K from 13 others

What the payments were for

  • Consulting fees$44,50962%
  • Speaking & faculty fees$2,0003%
  • Travel & lodging$16,38423%
  • Food & beverage$7,68111%
  • Education$7131%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$71,288 in reported general payments places this provider in the 95th percentile of 384 foot & ankle surgery providers in Michigan.

See all foot & ankle surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$27,311
Medicare patients
129
Services billed
245

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate22$434
Ketoconazole31$402
Ciclopirox22$377
Clotrimazole18$154
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$99
Ibuprofen23$78
Methylprednisolone15$73
Meloxicam11$20

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Dearborn

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →